Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
They need to lay open the RNS warts and all otherwise they run the risk of making things worse / not forgetting they had sight of RF finance issues back in January and no finance update since....
Reported stolen: capital letters, last seen on a computer screen just moments ago. WTF?
i presume rf are dumping shares simply to maximise tax losses for the current financial year ahead of whatever their own plans for readmission are. there was some apparent confusion posted the other day about whether riverfort were rgo or not, from the related rns the finance ****fest was with, "...riverfort global opportunities pcc ltd (the "investors" or "riverfort") as arranged by riverfort global capital ltd..." (perhaps their understanding of the word 'investor' is different to mine.)
anyway, in a best case scenario i think we'll get the interim results tomorrow stating they have enough funds to get the 1a data readout and this will form the basis of a new funding arrangement. this will buy the bod a short space of time. they could then do a public offering in the new financial year - punters getting cheap shares that they can have straight in their isas. if they take this approach i think they could get enough money to see us through 2024 & p1b. the bod would do well to also say they're on a reduced wage bill until the end of p1b.
as others have pointed out, the majority of shares are in the hands of punters and we want a fair return. as long as the bod don't act like weasels we can all profit.
if everything works out and new finance allows the sp to rebound then it might be worth remembering the cgt allowance for the next financial year will be just £3000 so if anyone has any shares (not just in sar) outside of an isa it might be worth getting your act together. this is not financial advice, just an observation.
fasten your seatbelts for tomorrow, it could get bumpy.
"If the UK government was serious about supporting UK businesses and startups...."
Oh Mr. Potnak you are a caution-'aven't laughed so much for a very long time!!
The Drones who inhabit that House of Shame on the Thames just spout rhetoric about the subject-in reality they don't give a Donald.
If the UK government was serious about supporting UK businesses and startups. They'd clean up AIM. No shorting, access to government unwritten short-term loans, better tax breaks and better protection for shareholders. The threat of prison for dodgy directors should sort that one.
I have been reading about the LSE in general and the destruction of Company valuations is rife across the board. It isn’t just Sareum. Larger firms are de-listing and re-listing elsewhere. TUI to Frankfurt etc due to low valuations. Direct Line has rejected a low ball offer as have other Companies. Private Equity firms trying it on. The analysis was done by….PH..well they would know wouldn’t they. More defections will follow. Even GGP.
The insider dealing and general disdain for genuine shareholders is driving investors and Companies away from LSE. I fear that hedge funds and shorters are killing the goose that lays the golden egg. We can’t all be wrong
Just waiting for the after-hours volume now. But it looks like RF could've offloaded another 200k or more, hopefully more.
Yes, the ask has been close to 14 most of the day so most are purchases for the brave, myself included with a tiny top up.
There all buys today over 13.5
16011 shows as sell
Out of all the scenarios i played out in my head. I think the same. More meat on the bones and details of the steps taken so far. Hopefully finishing with, we have enough funds to get to 1a data readout.
Unless they have inside information of course. Same applies to the Easter break - I suspect there has been a concerted push to get the sp down further ahead of buying back and closing out.
That being said I am not expecting much by way of information tomorrow, just a regurgitation of the facts from the last RNS but with more specifics. I sincerely hope I am wrong and we get an absolute stonker- not holding my breath though as, personally, I would release good news next week.
Just bought 16011 let’s see how that shows
Yes, and for all their Bravdo. I can't any of our new posters leaving a short open overnight. The chances of a 7am RNS is high.
And I know I had a go at Parker this morning saying he was a wheeler dealer. Having said that I do hope he's had his best Del Boy outfit on these last two weeks, cruising around the City in his Reliant Robin trying to get his mates to stump up a couple of ponies.
I'm reading that -55000 set of share trades from yesterday showing up today as possibly a short position closing. Someone got spooked at 0900 closed half and again just after 1400 and closed the rest of an £8000 trade. Maybe that was one of the rat's jumping out?
Glen, I'm on the same page. Sat through two big jumps, making a little off each one. Snowballed profits now into hopefully another 40x bagger or more?
All we need to worry about is securing enough funding to progress to p1a data readout. Hopefully the board can secure funding that offers the least amount of dilution as possible but I think we'll have to accept some level of dilution.
If this deal was on the table. We the shareholders have to approve it or it goes nowhere.
The list was courtesy of a gentleman called Brighty, I think. I agree, Potnak, things could turn around very quickly here. Remember, March 2020, 0.25p, to 10p (intraday) in July 2021. What a ride that was! Let's see tomorrow...
Saerum has always raised cash so we have to ask why BOD went to RF instead of share holders. Also why RF are crashing share price and why BOD show contempt for shareholders at AGM.
To my mind BOD are trying to ditch share holders and may already have a deal on the table for a takeover with RF and BODS controlling the share price and possible company sale. Time will tell
To add to my list. and i'm not an expert here, not even an amateur but say we take the lowest deal on the list circa 4 billion for a stage 2 asset. And a pharma only gives us a 10% chance of getting to market. Then even with a 90% discount. We're still looking at £400 million. The thing is if phase 1b is a success and shows a good immune response. The discount on good p1b data is considerably smaller. If we can't raise funds on the back of that sort of potential, we may as well just call it a day. This why some lth are still buying because if the board pull it off. It will be a legendary return from these levels.
I think Robin has been stood down as a result of his inability to understand what is going on.
Or may be back in the sin bin.
Not my list, can't remember who posted it but these are the size of deals we can expect if we get to phase 2 or 3.
Pfizer and Seagen. Deal size $43 Billion
2. Bristol Myers Squibb and Karuna Therapeutics Deal size $14 Billion
3. Merck and Prometheus Biosciences Deal size $10.8 Billion
4. AbbVie and ImmunoGen Deal size $10.1 Billion
5. AbbVie and Cerevel Therapeutics $8.7 Billion
6. Biogen and Reata Pharmaceuticals Deal size $7.3 Billion
7. Roche and Telavant Deal size $7.1 Billion
8. Astellas and Iveric Bio Deal size £5.9 Billion
9. Bristol Myers Squibb and Mirati Therapeutics Deal size $4.8 Billion
10. Bristol Myers Squibb and RayzeBio Deal size $4.1 Billion
You stated above dilution at 2p to.6p....obvious what you and the rest of the crew are at it.
Am with potnak....here all the way....rather lose the lot but I trust the science and it will be ok
...but agree with potnak ...no more aim....had my fingers burnt xcite energy , sirius minerals...enough